Why Cabot (CBT) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Buy Cabot (CBT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cabot's Stock Rises 16% in Three Months: What's Driving the Rally?
CBT's upside is fueled by strong segment performance, consistent earnings beats and an upbeat fiscal 2024 outlook.
5 Dividend Growth Stocks Likely to Outperform Amid Low Rates
NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.
Cabot Chosen for $50M Award Negotiation to Aid Battery Supply Chain
The new manufacturing operation of CBT will boost the domestic supply chain for crucial battery ingredients, lowering dependency on foreign imports.
Cabot's Shares Reach Fresh 52-Week High: What's Driving It?
CBT's shares hit a 52-week high, fueled by strong segment growth, higher earnings and an upbeat outlook on robust market demand.
Cabot Corporation (CBT) Hit a 52 Week High, Can the Run Continue?
Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Basic Materials Stocks Lagging Cabot (CBT) This Year?
Here is how Cabot (CBT) and Vista Gold (VGZ) have performed compared to their sector so far this year.
3 Reasons Why Growth Investors Shouldn't Overlook Cabot (CBT)
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.
Are Investors Undervaluing Cabot (CBT) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cabot's Shares Rise 18% in Six Months: What's Driving the Stock?
CBT's upside is fueled by strong segment performance, consistent earnings beat and an upbeat fiscal 2024 outlook.
5 Dividend Growth Stocks to Buy in Historically Weak September
Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.
